{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:43Z","timestamp":1787010163514,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/med.0b013e32835b896f","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T11:57:49Z","timestamp":1377863869000},"page":"8-13","source":"Crossref","is-referenced-by-count":41,"title":["Amylin and the regulation of appetite and adiposity"],"prefix":"10.1097","volume":"20","author":[{"given":"Jonathan D.","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000264394","article-title":"Roles of amylin in satiation, adiposity and brain development.","volume":"63","author":"Lutz","year":"2010","journal-title":"Forum Nutr"},{"key":"R2-3-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2011.02.015","article-title":"Amylinergic control of food intake in lean and obese rodents.","volume":"105","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1054-3589(05)52004-0","article-title":"Amylin and the integrated control of nutrient influx.","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(05)52001-5","article-title":"Historical background.","volume":"52","author":"Young","year":"2005","journal-title":"Adv Pharmacol"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2012.03.019","article-title":"Brainstem sensing of meal-related signals in energy homeostasis.","volume":"63","author":"Young","year":"2012","journal-title":"Neuropharmacology"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.peptides.2011.03.004","article-title":"Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.","volume":"32","author":"Qi","year":"2011","journal-title":"Peptides"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain.","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"R9-3-20211004","first-page":"493","article-title":"High affinity amylin binding sites in rat brain.","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol Pharmacol"},{"key":"R10-3-20211004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.brainres.2003.10.040","article-title":"Peripheral amylin activates circumventricular organs expressing calcitonin receptor ab subtypes and receptor-activity modifying proteins in the rat.","volume":"997","author":"Barth","year":"2004","journal-title":"Brain Res"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1152\/ajpregu.00333.2003","article-title":"The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis.","volume":"286","author":"Riediger","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"R405","DOI":"10.1152\/ajpregu.00103.2010","article-title":"Circulating signals as critical regulators of autonomic state--central roles for the subfornical organ.","volume":"299","author":"Smith","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1359\/jbmr.080310","article-title":"Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.","volume":"23","author":"Davey","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bone.2010.09.013","article-title":"The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption.","volume":"48","author":"Turner","year":"2011","journal-title":"Bone"},{"key":"R16-3-20211004","first-page":"413","article-title":"Modulating receptor function through RAMPs: can they represent drug targets in themselves Drug Discov T","volume":"14","author":"Sexton","year":"2009","journal-title":"oday"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/en.2009-0546","article-title":"Mechanisms of amylinleptin synergy in rodent models.","volume":"151","author":"Turek","year":"2010","journal-title":"Endocrinology"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db10-0692","article-title":"Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.","volume":"60","author":"Zhang","year":"2011","journal-title":"Diabetes"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tips.2011.05.007","article-title":"Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.","volume":"32","author":"Archbold","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/dc10-0518","article-title":"Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues: in vitro and ex vivo studies in humans.","volume":"34","author":"Moon","year":"2011","journal-title":"Diabetes Care"},{"key":"R22-3-20211004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-011-2332-0","article-title":"Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C(2)C(1)(2) muscle and AML12 liver cell lines.","volume":"55","author":"Moon","year":"2012","journal-title":"Diabetologia"},{"key":"R23-3-20211004","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2010.03.006","article-title":"Insights into amylin-leptin synergy.","volume":"21","author":"Trevaskis","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","article-title":"Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.","volume":"85","author":"Cooper","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"E924","DOI":"10.1152\/ajpendo.00198.2011","article-title":"Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.","volume":"302","author":"Kusakabe","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1210\/en.2006-0393","article-title":"Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.","volume":"147","author":"Roth","year":"2006","journal-title":"Endocrinology"},{"key":"R27-3-20211004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2007.06.016","article-title":"Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK.","volume":"1162","author":"Becskei","year":"2007","journal-title":"Brain Res"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.physbeh.2010.03.001","article-title":"Brainstem mechanisms of amylin-induced anorexia.","volume":"100","author":"Potes","year":"2010","journal-title":"Physiol Behav"},{"key":"R29-3-20211004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2010.03.114","article-title":"Identification of central projections from amylin-activated neurons to the lateral hypothalamus.","volume":"1334","author":"Potes","year":"2010","journal-title":"Brain Res"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"R1833","DOI":"10.1152\/ajpregu.2001.281.6.R1833","article-title":"Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP.","volume":"281","author":"Riediger","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"R623","DOI":"10.1152\/ajpregu.00791.2009","article-title":"Noradrenergic neurons of the area postrema mediate amylins hypophagic action.","volume":"299","author":"Potes","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"R340","DOI":"10.1152\/ajpregu.00380.2011","article-title":"Involvement of the extracellular signal-regulated kinase 12 signaling pathway in amylins eating inhibitory effect.","volume":"302","author":"Potes","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.12.022","article-title":"Amylin-leptin coadministration stimulates central histaminergic signaling in rats.","volume":"1442","author":"Seth","year":"2012","journal-title":"Brain Res"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0196-9781(02)00288-7","article-title":"Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin.","volume":"24","author":"Mollet","year":"2003","journal-title":"Peptides"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/oby.2011.81","article-title":"Melanocortin receptor 4 deficiency affects body weight regulation, grooming behavior, and substrate preference in the rat.","volume":"20","author":"Mul","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"R36-3-20211004","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1463-1326.2012.01570.x","article-title":"Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.","volume":"14","author":"Roth","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365521.2011.638392","article-title":"Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP.","volume":"47","author":"Olsson","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"E1112","DOI":"10.1152\/ajpendo.00395.2007","article-title":"Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.","volume":"293","author":"Roth","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-005-1732-4","article-title":"Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.","volume":"48","author":"Chapman","year":"2005","journal-title":"Diabetologia"},{"key":"R41-3-20211004","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","article-title":"Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.","volume":"12","author":"Hollander","year":"2004","journal-title":"Obes Res"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03350629","article-title":"Synthetic salmon calcitonin is not diabetogenic in patients with normal or impaired glucose metabolism.","volume":"8","author":"Giustina","year":"1985","journal-title":"J Endocrinol Invest"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.","volume":"51","author":"Karsdal","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1463-1326.2011.01425.x","article-title":"A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats.","volume":"13","author":"Feigh","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R45-3-20211004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1476-5381.2012.01979.x","article-title":"Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.","volume":"167","author":"Feigh","year":"2012","journal-title":"Br J Pharmacol"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1463-1326.2011.01465.x","article-title":"Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.","volume":"13","author":"Mack","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ijo.2009.238","article-title":"Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.","volume":"34","author":"Mack","year":"2010","journal-title":"Int J Obes (Lond)"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201302000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T22:27:04Z","timestamp":1633300024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201302000-00003"}},"subtitle":["recent advances in receptor signaling, neurobiology and pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32835b896f","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}